A Hospital-Based Registry of Preventive Cardiology Clinics
PREVENT-CARD
Assessment and Control of Modifiable Risk Factors for Primary and Secondary Prevention
1 other identifier
observational
10,000
1 country
1
Brief Summary
More research is needed to articulate the most effective ways to use these tools as screening tests in cardiovascular risk assessments and how they ultimately affect CVD mortality and morbidity outcomes. Clinicians are encouraged to continue sharing decision-making with patients to combine their unique cardiovascular risk factors and develop a comprehensive, effective treatment plan.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jun 2021
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 17, 2021
CompletedFirst Submitted
Initial submission to the registry
July 9, 2024
CompletedFirst Posted
Study publicly available on registry
July 16, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2031
ExpectedStudy Completion
Last participant's last visit for all outcomes
June 1, 2041
April 13, 2026
April 1, 2026
10 years
July 9, 2024
April 9, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
cardiovascular risk assesesment
risk stratification of Cardiovascular diseases (CVD) in patients without established CVD but with CVD co morbids.we are using Atherosclerotic Cardiovascular Diseases (ASCVD) Risk Score and World Heart Organization(WHO) Risk Score for CVD Risk Assesment. In ASCVD Risk Score, we categorize population into low risk ( score \<5), borderline(score between 5 and 7.4) ,intermediate( score between 7.5 an 19.9) and high risk (score\>20), using all parameters for risk assesment. For WHO risk score calculation we are using WHO Risk score system for South Asia. https://cdn.who.int/media/docs/default-source/cardiovascular-diseases/south-asia.pdf?sfvrsn=c5b0d9a3\_2
Ten years
Secondary Outcomes (2)
Cardiovascular risk reduction
Ten years
Cardiovascular related deaths
Ten years.
Study Arms (1)
Adult patients
Adult patients with or without cardiovascular diseases.
Interventions
Eligibility Criteria
Both genders, age 18 and above, visiting preventive cardiology clinics with or without established CVD and may or may not have CVD risk factors.
You may qualify if:
- All individuals attending the preventive cardiology clinics.
You may not qualify if:
- Individuals who refused to give consent.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
National Institute of Cardiovascular Diseases
Karachi, Sindh, 75510, Pakistan
Related Publications (1)
Rauf R, Khan MN, Sial JA, Qamar N, Saghir T, Kazmi KA. Primary prevention of cardiovascular diseases among women in a South Asian population: a descriptive study of modifiable risk factors. BMJ Open. 2024 Nov 14;14(11):e089149. doi: 10.1136/bmjopen-2024-089149.
PMID: 39542488DERIVED
Study Officials
- PRINCIPAL INVESTIGATOR
Dr Rubina Rauf
National Institute of Cardiovascular Diseases
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 10 Years
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor Preventive Cardiology
Study Record Dates
First Submitted
July 9, 2024
First Posted
July 16, 2024
Study Start
June 17, 2021
Primary Completion (Estimated)
June 1, 2031
Study Completion (Estimated)
June 1, 2041
Last Updated
April 13, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share